NCT02170116View on ClinicalTrials.gov

Pharmacodynamics, Safety and Pharmacokinetics After Oral Administration of BIBR 1048 MS in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

November 30, 1998

Primary Completion Date

December 31, 1998

Conditions
Healthy
Interventions
DRUG

BIBR 1048 MS dose 1

DRUG

BIBR 1048 MS dose 2

DRUG

BIBR 1048 MS dose 3

DRUG

BIBR 1048 MS dose 4

DRUG

BIBR 1048 MS dose 5

DRUG

Placebo to BIBR 1048 MS

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY